§¥§Ö§â§Ö§Ó§ñ§ß§ß§í§Ö §Õ§à§Þ§Ñ, §Ü§à§ä§à§â§í§Ö §Þ§à§Ø§ß§à §Ü§å§á§Ú§ä§î §Ó §¬§Ú§ä§Ñ§Ö, §Ó §¬§Ú§ä§Ñ§Ö.†Î£¬‡øÙÉúÎï(Goldsite Diagnostics Inc) ×÷žé65¼Ò«@ÅúµÄÉú®aÉÌÖ®Ò», Éú®aµÄSARS- §¯§¡§¢§°§² §¡§¯§´§ª§¤§¦§¯§¡ COV-2 (§¬§°§§§°§ª§¥§¯§°§¦ §©§°§§°§´§°) (§¥§§Á §³§¡§®§°§´§¦§³§´§ª§²§°§£§¡§¯§ª§Á)ƒÈ¿ìËÙ™zœyйڲ¡¶¾¸ÐȾ,¿É¿ìËÙÓÐЧµØÓÃì¶§±§¸§², §±§¸§², §±§¸§², §±§¸§², §±§¸§², §±§¸§², §±§¸§², §±§¸§², §±§¸§², §±§¸§², §±§¸§², §±§¸§², §±§¸§², §±§¸§², §±§¸§², §±§¸§², §±§¸§², §±§¸§², §±§¸§², §±§¸§², §±§¸§², §±§¸§², §±§¸§², §±§¸§², §±§¸§², §±§¸§², §±§¸§², §±§¸§², §±§¸§², §±§¸§², §±§¸§², §±§¸§², §±§¸§², §±§¸§², §±§¸§², §±§¸§², §±§¸§², §±§¸§².¼ºÔÚ¼Ò¼´¿É²Ù×÷£¬ŸoÐ茣˜IÈËÊ¿²Ù×÷£¬²»ÐèÒª¾ß‚äÑ}ësµÄátŒWÓ–¾š£¬¼´Ê¹ÊǃºÍ¯ºÍÀÏÈË,Ò²¿ÉÒÔ×ÔÐÐ’ñ˜Ó,¼È·½±ãÓÖ¿ÉÒÔ±ÜÃâ´óÒŽ
§¹§Ú§ä§Ñ§ä§î §¥§Ñ§Ý§Ö§Ö